MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2026 Evaluate
The quarter ended June 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3211.87 millions.An average growth of 43.66% was recorded for the quarter ended June 2026 to Rs. 690.37  millions from Rs. 480.56 millions.The company reported a good operating profit of 995.74 millions compared to 720.64 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3211.87 3197.34 0.45 3211.87 3197.34 0.45 13414.76 11743.74 14.23
Other Income 174.70 20.10 769.15 174.70 20.10 769.15 1035.33 657.87 57.38
PBIDT 995.74 720.64 38.17 995.74 720.64 38.17 4271.00 2738.85 55.94
Interest 3.40 3.02 12.58 3.40 3.02 12.58 13.27 11.74 13.03
PBDT 992.34 717.62 38.28 992.34 717.62 38.28 4257.73 2727.11 56.13
Depreciation 87.76 81.88 7.18 87.76 81.88 7.18 342.30 294.52 16.22
PBT 904.58 635.74 42.29 904.58 635.74 42.29 3915.43 2432.59 60.96
TAX 214.21 155.18 38.04 214.21 155.18 38.04 908.45 549.87 65.21
Deferred Tax 0.41 9.80 -95.82 0.41 9.80 -95.82 45.54 28.43 60.18
PAT 690.37 480.56 43.66 690.37 480.56 43.66 3006.98 1882.72 59.71
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 453.16 0.00
PBIDTM(%) 31.00 22.54 37.55 31.00 22.54 37.55 31.84 23.32 36.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..